Stocklytics Platform
Asset logo for symbol ZVRA
Zevra Therapeutics
ZVRA60
$8.79arrow_drop_up0.17%$0.01
High Growth
Asset logo for symbol ZVRA
ZVRA60

$8.79

arrow_drop_up0.17%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Zevra Therapeutics (ZVRA) Stocklytics Forecast

KemPharm Inc (ZVRA) is a pharmaceutical company specializing in the development of innovative drug products. With a strong focus on research and development, KemPharm is constantly working towards developing new treatments for various medical conditions. The company has a diverse pipeline of drug candidates, with several products in different stages of development.
When it comes to the stock price prediction for KemPharm Inc (ZVRA), there are several factors to consider. While it is difficult to predict the future performance of any stock with absolute certainty, there are some indicators that can help investors make informed decisions. One of these indicators is the stock price forecast, which is an estimate of the future value of a stock based on various factors such as historical performance, industry trends, and market conditions. However, it is important to note that stock price forecasts are not guarantees and should be viewed as estimates.
add Zevra Therapeutics to watchlist

Keep an eye on Zevra Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Zevra Therapeutics (ZVRA) stock?

Analysts have set a target price of $15.09 for Zevra Therapeutics (ZVRA), based on forecasts from 11 analysts. The predicted price range extends from a high of $25 to a low of $10. This represents a potential increase of up to 184.25% and a decrease of 13.7% from the current price of $8.79. These forecasts are as of 2015 May 11.
help

What are the analyst ratings for Zevra Therapeutics (ZVRA) stock?

Currently, there are no analyst ratings available for Zevra Therapeutics (ZVRA), possibly due to insufficient coverage or recent updates.
help

What is the AI price prediction for Zevra Therapeutics (ZVRA) stock?

At present, there is no AI or machine-learning-based price prediction available for Zevra Therapeutics (ZVRA) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level